Untreated, mdr tb is a deadly disease affecting impoverished people who cannot afford timely diagnosis and adequate treatment for this curable illness. The treatment outcomes of mdr tb were assessed in ethiopia and china, and a clinical risk score was developed for the prediction of poor treatment outcomes. A total of 439 medical records belonging to mdr tb and non mdr tb patients managed in public health centres from january 2008 to december 2011 were analysed. Costs faced by multidrug resistant tuberculosis patients during. A drug resistance survey conducted in 2011 in somalia showed that the country had the highest rate of mdr tb infection on the african continent. The last national survey on the prevalence of drugresistant tb in lebanon was performed 15 years ago, well before the beginning of the syria crisis in 2011. Prevalence of multidrugresistant tuberculosis and associated.
Ethiopia has a high prevalence of tuberculosis tb and is one of the 22 highest tb. This set of tools is designed to help countries develop or strengthen a multidrugresistant tuberculosis mdr tb component within their national tb strategy. Risk factors for multidrug resistant tuberculosis in. Study subjects were selected using multistage probability sampling. However, growing evidence shows that low treatment success rate and high rates of adverse events are associated with this regimen. Oct 03, 2014 likewise, two studies reported xdrtb in the range of 1% 4. Epidemiology of multidrugresistant tuberculosis mdrtb. Pdf the emergence of drugresistant tuberculosis tb, particularly multidrug resistant mdr and extensively drugresistant xdr tb, is a major. In addition, studies in zimbabwe, south africa, and ethiopia associate high. Jan 22, 2017 kncv tuberculosis foundation is looking for a fulltime. Our resources improve and expand tb diagnostic and treatment services and screening in rural areas and among. Spatial patterns of multidrug resistant tuberculosis and relationships to socioeconomic, demographic and household factors in northwest ethiopia kefyalew addis alene1,2, kerri viney1, emma s. This edition also addresses the prevention of acquired mdr tb, especially among new tb patients. Ethiopia tuberculosis profile world health organization.
Review open access multidrugresistant tuberculosis in. These levels of drug resistance are among the highest ever documented in africa and the middle east. Up to date, the mdrtb treatment outcome is not sufficiently understood in ethiopia. Experts involved in the development of the who treatment guidelines for drugresistant tb. Ethiopia is one of the countries with high multidrugresistant tuberculosis mdr tb burden. According to the 2014 who global tb report, 22 high burden countries account for 80 percent of the global tb cases and ethiopia has the tenth highest tb burden in the world. According to the who report, the prevalence of mdr tb has been 2. In 2017 an estimate indicated that the incidence of mdr tb in ethiopia is 2. The main aim of the report is to provide a comprehensive and uptodate assessment of the tb epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. According to the who report, the prevalence of mdr. Efforts by the national tb programme to control mdr tb include expanding ambulatory care. To investigate the opportunities and challenges faced by treatment followup health centres tfcs when managing mdr tb patients, with greater focus on recording, tb infection control ic and. Guidelines fourth, diagnosing mdr tb cases among previously treated patients and providing effective treatment will greatly help in halting the spread of mdr tb.
Ethiopia is one of the 30 mdrtb highburden countries, with an estimated 5800 cases reported in 2016 with the prevalence rate of 2. Mdr tb planning toolkit introduction and users guide 3 mdr tb planning toolkit introduction and users guide. Mdr tb, rifapentine for pregnant women and children with latent tb infection ltbi. To determine risk factors of mdrtb patients in amhara national regional state, ethiopia. The thesis identified the areas where tb and mdr tb are clustered in northwest ethiopia. Dec 21, 2014 the national tb programme ntp is responsible for the programmatic management of mdr tb in ethiopia. This study identifies factors associated with the occurrence of mdr tb in patients who underwent firstline tb treatment in addis. M workshop facing the reality of mdr tb new delhi, india. This study identifies factors associated with the occurrence of mdr tb in patients who underwent firstline tb treatment in addis ababa city.
Ethiopia is among the countries highly affected with mdr tb. Pdf the emergence of drugresistant tuberculosis tb, particularly multidrugresistant mdr and extensively drugresistant xdr tb, is a major. The emergence of drugresistant tuberculosis tb, particularly multidrugresistant mdr and extensively drugresistant xdr tb, is a major public health problem. Ethiopia tuberculosis profile population 2018 109 million estimates of tb burden. The thesis provided some policy recommendations that could assist to achieve the endtb targets. Adverse drug reactions in management of multi drug resistant. Risk factors for multidrug resistant tuberculosis patients in. Pdf severe adverse effects associated with multidrug. Multidrugresistant tuberculosis mdrtb has continued to be a challenge for tuberculosis tb control globally. Tracing symptomatic contacts of mdr tb cases could be a high yield strategy for early detection and treatment of mdr tb cases in the community. A study of mdrtb patient costs in march 20 indicated that the average total.
Current treatment of multidrug resistant tuberculosis in. Therefore, this study determined risk factors for mdr tb among. Multidrug resistant tuberculosis in ethiopian settings and its. In addition, these findings need to be corroborated with multicentre casecontrol studies to bring out nationally relevant risk factors for mdr tb. Tb usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. Kncv is the lead partner in challenge tb, the usaidfunded 5year global program to decrease tb mortality and morbidity in high burdened countries. Who treatment guidelines for drug resistant tuberculosis. We analyzed a previously published collection of m. Risk factors for multidrugressistant tuberculosis in addis ababa, ethiopia by fikadu tadesse nigusso submitted in accordance with the requirements for the degree of. This finding presents a serious challenge for tb control in somalia. Tuberculosis tb is a disease caused by bacteria that are spread from person to person through the air. The result of this study highlight treatment success among mdrtb is below acceptable.
Mdr and non mdr tb cases were compared on key sociodemographic and patient. Prevalence of tuberculosis, multidrug resistant tuberculosis and. Jun 04, 2017 new ethiopian tb guildline november 2016 1. Pdf tuberculosis burden in ethiopia from 1990 to 2016. Efforts to control the global burden of tuberculosis tb have been jeopardized by the rapid evolution of multidrug resistant mycobacterium tuberculosis mtb, which is resistant to at least isoniazid and rifampicin. Wondemagegn mulu1, daniel mekonnen1, mulat yimer1, aschalew admassu2, bayeh abera1 1. There is a paucity of evidence that assessed studies on the treatment of mdr tb, which focus on the effectiveness of the directly. Aug 28, 20 worldwide, there were 650,000 multidrugresistant tuberculosis mdr tb cases in 2010, and in 2008 the world health organization estimated that 150,000 deaths occurred annually due to mdr tb. Lineprobe assay and molecular typing reveal a potential drug. The identified risk factors should be given priority by tb control programs under addis ababa health bureau to control mdr tb. Determinants of multidrugresistant tuberculosis in patients.
Comparative crosssectional study was conducted to determine the risk factors for mdr tb in addis ababa. Open access research drugsusceptible tuberculosis treatment. Likewise, two studies reported xdr tb in the range of 1% 4. Mdr rrtb cases started on secondline treatment in 2016 72% 703 xdrtb cases started on secondline treatment in 2016 tb preventive treatment, 2018. The yield of screening symptomatic contacts of multidrug.
The approach should be promoted for wider adoption and dissemination. This quantitative, descriptive study investigated risk factors for mdr tb in addis ababa, ethiopia. Risk factors for multidrug resistant tuberculosis patients in amhara. Studies that reported a prevalence of mdrtb among new and previously. Mdr tb develops when a patient receives ineffective treatment or treatment is interrupted, a common occurrence when people are subjected to violence and insecurity. New ethiopian tb guildline november 2016 slideshare. This study aimed to assess the level of pulmonary tuberculosis ptb preventive practices. Mdrtb clinicianinternist addis ababa, ethiopia kncv. Also, in 2016 about 19% of previously treated tb cases were estimated to have either rifampicin or multi drug resistant tb. In this study, we used the 2016 global burden of diseases, injuries and risk. Secondline drug susceptibility testing dst and individualized xdr. Antituberculosis drug resistance is a major public health problem that threatens the progress made in tuberculosis care and control worldwide. Tuberculosis tb is a chronic infectious disease caused by mycobacterium tuberculosis.
This study aimed to assess the level of pulmonary tuberculosis ptb preventive practices and. The most powerful predictor of the emergence of mdr tb reported in ethiopia is previous exposure to antitb drug treatment. The objective of the study was to investigate risk factors for mdr tb in addis ababa. Similarly, a study in north shoa, ethiopia has also shown a high prevalence 23. Global tuberculosis report 2019 who has published a global tb report every year since 1997. Mdr rr tb cases started on secondline treatment in 2016 72% 703 xdr tb cases started on secondline treatment in 2016 tb preventive treatment, 2018. Ethiopia is also one of the 27 high mdr tb burden countries.
Pdf cdc pdf 37k multidrugresistant tuberculosis mdr tb what is tuberculosis tb. The most powerful predictor of the emergence of mdr tb reported in ethiopia is previous exposure to anti tb drug treatment. In this study, we used the 2016 global burden of diseases, injuries and risk factors gbd data to analyze the incidence, prevalence and mortality rates of tuberculosis tb in ethiopia over the. Epidemiology of multidrugresistant tuberculosis mdrtb in. Rifampicin resistance was lower than 2% in new cases. Efforts to expand diagnostic services, treatment and care.
However, to our knowledge, no study was done to assess risk factors for multi drug resistant tuberculosis targeting mdrtbhiv and tbhiv patients. The burden of mdrtb remains high in ethiopian settings, especially in. Even most recent reported mdr tb rates largely relied on estimates rather than on systematic laboratory confirmation. Multidrug resistant tuberculosis in ethiopian settings and. Treatment outcomes for multidrugresistant tuberculosis. According to the national sentinel drug resistance survey conducted in 20122014, 2. Pulmonary tuberculosis preventive practices among anibessa. Kncv tuberculosis foundation is looking for a fulltime. The diagnosis of mdr tb can take several months or even longer often too late for the patient. Surveillance of drug resistance tuberculosis based on. Ethiopia is among the 30 high tb, hiv and mdr tb burden countries, with annual estimated tb incidence of 177100,000 populations and death rate of 25 per 100,000 populations for 2016. Clements1 1 research school of population health, college of medicine, biology and environment, the australian. Determinants of multidrugresistant tuberculosis in.
Risk factors of multidrug resistant tuberculosis in addis. However, little is known about pulmonary tuberculosis preventive practices among bus users in ethiopia. Adverse drug reactions in management of multi drug. Pdf current treatment of multidrug resistant tuberculosis in. The burden of tuberculosis tb has not been comprehensively evaluated over the last 25 years in ethiopia. In a nationwide survey in 2011, multidrugresistant tuberculosis mdr tb was found in 5. Worldwide, there were 650,000 multidrugresistant tuberculosis mdr tb cases in 2010, and in 2008 the world health organization estimated that 150,000 deaths occurred annually due to mdr tb.
Current treatment of multidrug resistant tuberculosis in ethiopia. Spatial patterns of multidrug resistant tuberculosis and. Ethiopia is one of the high multidrugresistant tuberculosis mdr tb burden countries. Ethiopia is 15th among the 27 mdr tb highburden countries. The rate of successful treatment outcome in ethiopia appears generally high. Drugresistant tuberculosis, lebanon, 2016 2017 volume. Federal democratic republic of ethiopia ministry of health. Management of these adverse reactions symptomatically withwithout modification of the mdr tb regimen was noted if documented in the case file treatment card. Likewise, two studies reported xdrtb in the range of 1% 4.
The programmatic management of multidrugresistant tuberculosis mdr tb is entirely based on a who recommended longterm, 1824 month lasting treatment regimen. The main source of infection is untreated smearpositive pulmonary. Links with this icon indicate that you are leaving the cdc website the centers for disease control and prevention cdc cannot attest to the accuracy of a nonfederal website. Tuberculosis treatment outcomes in ethiopia from 2003 to. Risk factors for multidrug resistant tuberculosis patients. Multidrug resistant tuberculosis mdr tb is becoming a major challenge of the tuberculosis tb control program in ethiopia. This study determined risk factors associated with mdr tb among mdr tbhiv coinfected cases and tbhiv coinfected controls attending art clinics in addis ababa. Provided by the centers for disease control and prevention cdc. Although the burden of mdr tb in ethiopia is increasing, there is. Treatment success rates of multidrugresistant tuberculosis mdr tb is a key issue that cannot be ignored. Up to date, the mdr tb treatment outcome is not sufficiently understood in ethiopia. Drugresistant tb continues to be a public health crisis. Therefore, this analysis aimed to determine the pooled. Annually 20002500 mdr tb cases are estimated to occur among the notified pulmonary tb cases.
Lineprobe assay and molecular typing reveal a potential. Improving tuberculosis control in ethiopia 1 daniel gemechu datiko 1. Phd thesis improving tuberculosis control in ethiopia. Cases of multidrugresistant tuberculosis mdrtb are rising, which is a. Department of medical microbiology, immunology and parasitology, college of medicine and health sciences, bahir dar university, ethiopia 2. Multidrugresistant tuberculosis, somalia, 20102011. Free fulltext pdf articles from hundreds of disciplines, all in one place multidrugresistant tuberculosis in ethiopia. Linking to a nonfederal website does not constitute an endorsement by cdc or any of its employees of the sponsors or the information and products presented on the website.
1263 988 801 1180 965 735 1411 299 1487 500 154 1156 926 78 560 191 843 1039 578 324 163 1459 738 967 1660 778 1491 1073 311 1116 956 445 427 610 597